Enhanced deposition of cartilage oligomeric matrix protein is a common feature in fibrotic skin pathologies

Matrix Biology

Volumn 32, Issue 6, 2013, Pages 325-331

  Agarwal, Pallavi ^a   Schulz, Jan Niklas ^a   Blumbach, Katrin ^a   Andreasson, Kristofer ^b   Heinegård, Dick ^b   Paulsson, Mats ^a   Mauch, Cornelia ^a   Eming, Sabine A ^a   Eckes, Beate ^a   Krieg, Thomas ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Basal cell carcinoma; Chronic wounds; Collagen fibrils; COMP; ECM organization; Fibroplastic stroma response

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN FIBRIL; SCLEROPROTEIN;

ARTICLE; BASAL CELL CARCINOMA; CELL DIFFERENTIATION; CHRONIC WOUND; CONTROLLED STUDY; EPITHELIUM TUMOR; EPITHELIZATION; EXTRACELLULAR MATRIX; FIBROBLAST; GRANULATION TISSUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KELOID; LOCALIZED SCLERODERMA; MYOFIBROBLAST; PRIORITY JOURNAL; PUNCH BIOPSY; SCAR; SCLERODERMA; SKIN BIOPSY; SKIN FIBROSIS; SYSTEMIC SCLEROSIS; TUMOR GROWTH; ULCER; WESTERN BLOTTING; WOUND FLUID; WOUND HEALING;

EID: 84882626587     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2013.02.010     Document Type: Article

References (42)

1. Agarwal P., Zwolanek D., Keene D.R., Schulz J.N., Blumbach K., Heinegard D., Zaucke F., Paulsson M., Krieg T., Koch M., Eckes B. Collagen XII and XIV, new partners of cartilage oligomeric matrix protein in the skin extracellular matrix suprastructure. J. Biol. Chem. 2012, 287:22549-22559.
2. Bayer M.L., Yeung C.Y., Kadler K.E., Qvortrup K., Baar K., Svensson R.B., Magnusson S.P., Krogsgaard M., Koch M., Kjaer M. The initiation of embryonic-like collagen fibrillogenesis by adult human tendon fibroblasts when cultured under tension. Biomaterials 2010, 31:4889-4897.
3. Briggs M.D., Hoffman S.M., King L.M., Olsen A.S., Mohrenweiser H., Leroy J.G., Mortier G.R., Rimoin D.L., Lachman R.S., Gaines E.S., et al. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat. Genet. 1995, 10:330-336.
4. Buchstein N., Hoffmann D., Smola H., Lang S., Paulsson M., Niemann C., Krieg T., Eming S.A. Alternative proteolytic processing of hepatocyte growth factor during wound repair. Am. J. Pathol. 2009, 174:2116-2128.
5. Buxboim A., Ivanovska I.L., Discher D.E. Matrix elasticity, cytoskeletal forces and physics of the nucleus: how deeply do cells 'feel' outside and in?. J. Cell Sci. 2010, 123:297-308.
6. Eckes B., Nischt R., Krieg T. Cell-matrix interactions in dermal repair and scarring. Fibrogenesis Tissue Repair 2010, 3:4.
7. Erler J.T., Weaver V.M. Three-dimensional context regulation of metastasis. Clin. Exp. Metastasis 2009, 26:35-49.
8. Farina G., Lemaire R., Korn J.H., Widom R.L. Cartilage oligomeric matrix protein is overexpressed by scleroderma dermal fibroblasts. Matrix Biol. 2006, 25:213-222.
9. Farina G., Lemaire R., Pancari P., Bayle J., Widom R.L., Lafyatis R. Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta. Ann. Rheum. Dis. 2009, 68:435-441.
10. Gabbiani G., Ryan G.B., Majne G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971, 27:549-550.
11. Gabbiani G., Hirschel B.J., Ryan G.B., Statkov P.R., Majno G. Granulation tissue as a contractile organ. A study of structure and function. J. Exp. Med. 1972, 135:719-734.
12. Gabrielli A., Avvedimento E.V., Krieg T. Scleroderma. N. Engl. J. Med. 2009, 360:1989-2003.
13. Gardner H., Shearstone J.R., Bandaru R., Crowell T., Lynes M., Trojanowska M., Pannu J., Smith E., Jablonska S., Blaszczyk M., Tan F.K., Mayes M.D. Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts. Arthritis Rheum. 2006, 54:1961-1973.
14. Giannoni P., Siegrist M., Hunziker E.B., Wong M. The mechanosensitivity of cartilage oligomeric matrix protein (COMP). Biorheology 2003, 40:101-109.
15. Gurtner G.C., Werner S., Barrandon Y., Longaker M.T. Wound repair and regeneration. Nature 2008, 453:314-321.
16. Halász K., Kassner A., Mörgelin M., Heinegård D. COMP acts as a catalyst in collagen fibrillogenesis. J. Biol. Chem. 2007, 282:31166-31173.
17. Hansen U., Bruckner P. Macromolecular specificity of collagen fibrillogenesis: fibrils of collagens I and XI contain a heterotypic alloyed core and a collagen I sheath. J. Biol. Chem. 2003, 278:37352-37359.
18. Haudenschild D.R., Hong E., Yik J.H., Chromy B., Moergelin M., Snow K.D., Acharya C., Takada Y., Di Cesare P.E. Enhanced activity of TGF-beta1 bound to cartilage oligomeric matrix protein. J. Biol. Chem. 2011, 286:43250-43258.
19. Hecht J.T., Nelson L.D., Crowder E., Wang Y., Elder F.F., Harrison W.R., Francomano C.A., Prange C.K., Lennon G.G., Deere M., et al. Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nat. Genet. 1995, 10:325-329.
20. Hedbom E., Antonsson P., Hjerpe A., Aeschlimann D., Paulsson M., Rosa-Pimentel E., Sommarin Y., Wendel M., Oldberg Å., Heinegård D. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J. Biol. Chem. 1992, 267:6132-6136.
21. Heinegård D., Saxne T. The role of the cartilage matrix in osteoarthritis. Nat. Rev. Rheumatol. 2011, 7:50-56.
22. Hinz B., Phan S.H., Thannikal V.J., Prunotto M., Desmouliere A., Varga J., De Wever O., Mareel M., Gabbiani G. Recent developments in myofibroblast biology. Am. J. Pathol. 2012, 180:1340-1355.
23. Holden P., Meadows R.S., Chapman K.L., Grant M.E., Kadler K.E., Briggs M.D. Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. J. Biol. Chem. 2001, 276:6046-6055.
24. Inui S., Shono F., Nakajima T., Hosokawa K., Itami S. Identification and characterization of cartilage oligomeric matrix protein as a novel pathogenic factor in keloids. Am. J. Pathol. 2011, 179:1951-1960.
25. Kessler D., Dethlefsen S., Haase I., Plomann M., Hirche F., Krieg T., Eckes B. Fibroblasts in mechanically stressed collagen lattices assume a "synthetic" phenotype. J. Biol. Chem. 2001, 276:36575-36585.
26. Krieg T., Aumailley M. The extracellular matrix of the dermis: flexible structures with dynamic functions. Exp. Dermatol. 2011, 20:689-695.
27. Lauer G., Sollberg S., Cole M., Flamme I., Sturzebecher J., Mann K., Krieg T., Eming S.A. Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J. Invest. Dermatol. 2000, 115:12-18.
28. Liu F., Mih J.D., Shea B.S., Kho A.T., Sharif A.S., Tager A.M., Tschumperlin D.J. Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression. J. Cell Biol. 2010, 190:693-706.
29. Moor A.N., Vachon D.J., Gould L.J. Proteolytic activity in wound fluids and tissues derived from chronic venous leg ulcers. Wound Repair Regen. 2009, 17:832-839.
30. Niehoff A., Muller M., Bruggemann L., Savage T., Zaucke F., Eckstein F., Muller-Lung U., Bruggemann G.P. Deformational behaviour of knee cartilage and changes in serum cartilage oligomeric matrix protein (COMP) after running and drop landing. Osteoarthritis Cartilage 2011, 19:1003-1010.
31. Oldberg Å., Antonsson P., Lindblom K., Heinegård D. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J. Biol. Chem. 1992, 267:22346-22350.
32. Perlish J.S., Lemlich G., Fleischmajer R. Identification of collagen fibrils in scleroderma skin. J. Invest. Dermatol. 1988, 90:48-54.
33. Rayment E.A., Upton Z., Shooter G.K. Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer. Br. J. Dermatol. 2008, 158:951-961.
34. Rosenberg K., Olsson H., Mörgelin M., Heinegård D. Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. J. Biol. Chem. 1998, 273:20397-20403.
35. Sargent J.L., Milano A., Bhattacharyya S., Varga J., Connolly M.K., Chang H.Y., Whitfield M.L. A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity. J. Invest. Dermatol. 2010, 130:694-705.
36. Sorrell J.M., Caplan A.I. Fibroblast heterogeneity: more than skin deep. J. Cell Sci. 2004, 117:667-675.
37. Tan F.K., Hildebrand B.A., Lester M.S., Stivers D.N., Pounds S., Zhou X., Wallis D.D., Milewicz D.M., Reveille J.D., Mayes M.D., Jin L., Arnett F.C. Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease. Arthritis Rheum. 2005, 52:865-876.
38. Thur J., Rosenberg K., Nitsche D.P., Pihlajamaa T., Ala-Kokko L., Heinegård D., Paulsson M., Maurer P. Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX. J. Biol. Chem. 2001, 276:6083-6092.
39. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 2002, 3:349-363.
40. Trachslin J., Koch M., Chiquet M. Rapid and reversible regulation of collagen XII expression by changes in tensile stress. Exp. Cell Res. 1999, 247:320-328.
41. Vaughan L., Mendler M., Huber S., Bruckner P., Winterhalter K.H., Irwin M.I., Mayne R. D-periodic distribution of collagen type IX along cartilage fibrils. J. Cell Biol. 1988, 106:991-997.
42. Wipff P.J., Hinz B. Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship. Eur. J. Cell Biol. 2008, 87:601-615.